Skip to main content
SpringerLink
Log in

Using Continuous Glucose Monitoring for Steroid-Induced Diabetes

  • Chapter
  • First Online:
Continuous Glucose Monitoring

  • 1119 Accesses

Abstract

The prevalence of steroid diabetes, also known as steroid-induced diabetes or glucocorticoid-induced diabetes, has varied widely among studies. Excessive exogenous glucocorticoids can reduce insulin sensitivity and impair islet function, thereby increasing blood glucose. Excessive endogenous glucocorticoids (commonly seen in Cushing’s syndrome) share a similar mechanism in abnormalities of glucose metabolism and are also introduced in this chapter. Unlike common types of diabetes, steroid diabetes has its own unique glycemic characteristics. In cases of steroid diabetes caused by once-daily morning administration of prednisone, patients typically present with predominant postprandial hyperglycemia (especially after lunch and dinner) and mildly elevated fasting blood glucose or even hypoglycemia. Therefore, special attention should be paid in such patients to monitor postprandial blood glucose in order to facilitate timely diagnosis. This chapter introduces the glycemic characteristics of steroid diabetes and Cushing’s syndrome as well as the corresponding screening and treatment strategies in five practical cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Xiang KS. Special types of diabetes mellitus. Shanghai: Shanghai Scientific and Technical; 2011.

    Google Scholar 

  2. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014;30:96–102. https://doi.org/10.1002/dmrr.2486.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Ingle DJ, Winter HA, Li CH, Evans HM. Production of glycosuria in normal rats by means of adrenocorticotrophic hormone. Science. 1945;101:671–2. https://doi.org/10.1126/science.101.2635.671.

    Article  PubMed  CAS  Google Scholar 

  4. Munir A, Newell-Price J. Management of diabetes mellitus in Cushing’s syndrome. Neuroendocrinology. 2010;92(Suppl 1):82–5. https://doi.org/10.1159/000314316.

    Article  PubMed  CAS  Google Scholar 

  5. Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med. 2002;17:717–20. https://doi.org/10.1046/j.1525-1497.2002.10649.x.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gulliford MC, Charlton J, Latinovic R. Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care. 2006;29:2728–9. https://doi.org/10.2337/dc06-1499.

    Article  PubMed  CAS  Google Scholar 

  7. Jin JY, DuBois DC, Almon RR, Jusko WJ. Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver. J Pharmacol Exp Ther. 2004;309:328–39. https://doi.org/10.1124/jpet.103.061515.

    Article  PubMed  CAS  Google Scholar 

  8. Vander Kooi BT, Onuma H, Oeser JK, Svitek CA, Allen SR, Vander Kooi CW, Chazin WJ, O’Brien RM. The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol. 2005;19:3001–22. https://doi.org/10.1210/me.2004-0497.

    Article  PubMed  CAS  Google Scholar 

  9. Kraus-Friedmann N. Hormonal regulation of hepatic gluconeogenesis. Physiol Rev. 1984;64:170–259.

    Article  CAS  PubMed  Google Scholar 

  10. Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man. Clin Nutr. 2000;19:29–34. https://doi.org/10.1054/clnu.1999.0064.

    Article  PubMed  CAS  Google Scholar 

  11. Ruzzin J, Wagman AS, Jensen J. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia. 2005;48:2119–30. https://doi.org/10.1007/s00125-005-1886-0.

    Article  PubMed  CAS  Google Scholar 

  12. Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E, Waldhäusl W, Roden M. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes. 2002;51:599–605.

    Article  CAS  PubMed  Google Scholar 

  13. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):6–11. https://doi.org/10.1038/sj.ijo.0802491.

    Article  CAS  Google Scholar 

  14. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8. https://doi.org/10.1111/j.1467-789X.2009.00623.x.

    Article  PubMed  Google Scholar 

  15. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46:1594–603. https://doi.org/10.1007/s00125-003-1228-z.

    Article  PubMed  CAS  Google Scholar 

  16. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97. https://doi.org/10.1038/nri2921.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Penfornis A, Kury-Paulin S. Immunosuppressive drug-induced diabetes. Diabetes Metab. 2006;32:539–46. https://doi.org/10.1016/s1262-3636(06)72809-9.

    Article  PubMed  CAS  Google Scholar 

  18. Ranta F, Avram D, Berchtold S, Düfer M, Drews G, Lang F, Ullrich S. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes. 2006;55:1380–90.

    Article  CAS  PubMed  Google Scholar 

  19. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol. 2004;61:768–77. https://doi.org/10.1111/j.1365-2265.2004.02168.x.

    Article  Google Scholar 

  20. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R, Papadopoulos NM, Chrousos GP. Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J. 1996;43:645–55.

    Article  CAS  PubMed  Google Scholar 

  21. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87:998–1003. https://doi.org/10.1210/jcem.87.3.8277.

    Article  PubMed  CAS  Google Scholar 

  22. Magee MH, Blum RA, Lates CD, Jusko WJ. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 2001;41:1180–94. https://doi.org/10.1177/00912700122012733.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Burt MG, Roberts GW, Aguilar-Loza NR, Frith P, Stranks SN. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab. 2011;96:1789–96. https://doi.org/10.1210/jc.2010-2729.

    Article  PubMed  CAS  Google Scholar 

  24. van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34:412–7. https://doi.org/10.2337/dc10-1677.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University, Affiliated Sixth People’s Hospital, Shanghai, China

    J. Y. Lu & W. Jia

Authors
  1. J. Y. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Jia .

Editor information

Editors and Affiliations

  1. Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

    Weiping Jia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lu, J.Y., Jia, W. (2018). Using Continuous Glucose Monitoring for Steroid-Induced Diabetes. In: Jia, W. (eds) Continuous Glucose Monitoring. Springer, Singapore. https://doi.org/10.1007/978-981-10-7074-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7074-7_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7073-0

  • Online ISBN: 978-981-10-7074-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation